Evidence map›Paper›PMID 42657169›Full record

ArticleHuman mutation2026

Computational Characterization of Pathogenic LMNA Missense Variants: Structural Instability, Altered Binding, and Conformational Dynamics.

Emre Aktaş, Ceren Nizamoğlu, Salvador Ventura

Abstract read
In one paragraph

Article in Human mutation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Emre AktaşDepartment of Molecular Biology and Genetics, Faculty of Arts and Sciences, Yıldız Technical University, Istanbul, Türkiye, yildiz.edu.tr.ORCID https://orcid.org/0000-0002-9422-3402
Ceren NizamoğluDepartment of Molecular Biology and Genetics, Faculty of Arts and Sciences, Yıldız Technical University, Istanbul, Türkiye, yildiz.edu.tr.ORCID https://orcid.org/0009-0008-3467-7913
Salvador VenturaInstitut de Biotecnologia i de Biomedicina and Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain, uab.cat.ORCID https://orcid.org/0000-0002-9652-6351

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Mutations in the Methods: An integrated multistep in silico framework was employed to investigate the structural and functional consequences of Results: Evo2-based screening of the full LMNA coding sequence identified 50 high-priority loss-of-function variants, of which N456D, N456T, and G465D were retained for structural investigation based on their globular domain localization and multitool pathogenicity predictions. All three variants were consistently predicted to alter physicochemical properties and reduce structural stability relative to wild-type Lamin A. Molecular docking revealed mutation-dependent changes in lonafarnib binding profiles. The known pathogenic control M540T exhibited comparable structural and dynamic behavior, supporting the reliability of the prioritization workflow. Molecular dynamics analyses demonstrated altered RMSD trajectories, increased residue-level flexibility, and modified hydrogen bonding patterns in mutant systems. Free-energy landscape analyses revealed expanded conformational basins, particularly pronounced in the G465D variant, indicating increased structural plasticity. Conclusion: This integrated computational framework provides a systematic strategy for prioritizing pathogenic

Indexed as

Computational BiologyLamin Type AMutation, MissenseHumansMolecular Docking SimulationMolecular Dynamics SimulationProtein BindingProtein ConformationProtein StabilityLamin Type ALMNA protein, humanEvo2intrinsic disorderLamin Alaminopathiesloss-of-function variantsmolecular dockingmolecular dynamicsprotein structurevariant prioritization

Identifiers

PMID42657169
PMCPMC13508025

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.